ATE554781T1 - Onkolytische viren zur sensibilisierung neoplastischer zellen für die strahlentherapie - Google Patents
Onkolytische viren zur sensibilisierung neoplastischer zellen für die strahlentherapieInfo
- Publication number
- ATE554781T1 ATE554781T1 AT03724713T AT03724713T ATE554781T1 AT E554781 T1 ATE554781 T1 AT E554781T1 AT 03724713 T AT03724713 T AT 03724713T AT 03724713 T AT03724713 T AT 03724713T AT E554781 T1 ATE554781 T1 AT E554781T1
- Authority
- AT
- Austria
- Prior art keywords
- radiation therapy
- neoplastic cells
- oncolytic viruses
- sensitizing neoplastic
- sensitizing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37894802P | 2002-05-10 | 2002-05-10 | |
| US44318903P | 2003-01-29 | 2003-01-29 | |
| PCT/CA2003/000695 WO2003094939A1 (en) | 2002-05-10 | 2003-05-08 | Sensitization of neoplastic cells to radiation therapy with oncolytic viruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE554781T1 true ATE554781T1 (de) | 2012-05-15 |
Family
ID=29423650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03724713T ATE554781T1 (de) | 2002-05-10 | 2003-05-08 | Onkolytische viren zur sensibilisierung neoplastischer zellen für die strahlentherapie |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7198783B2 (de) |
| EP (1) | EP1505993B1 (de) |
| JP (1) | JP4546823B2 (de) |
| AR (1) | AR039997A1 (de) |
| AT (1) | ATE554781T1 (de) |
| AU (1) | AU2003229180B8 (de) |
| BR (1) | BR0311448A (de) |
| CA (1) | CA2482826C (de) |
| DK (1) | DK1505993T3 (de) |
| ES (1) | ES2386779T3 (de) |
| IL (1) | IL164593A (de) |
| MX (1) | MXPA04011067A (de) |
| NZ (1) | NZ536062A (de) |
| PT (1) | PT1505993E (de) |
| SI (1) | SI1505993T1 (de) |
| TW (1) | TWI300715B (de) |
| WO (1) | WO2003094939A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| US6565831B1 (en) * | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| US20040115170A1 (en) * | 2001-11-30 | 2004-06-17 | Brown Earl Garnet | Oncolytic virus |
| US20050171396A1 (en) * | 2003-10-20 | 2005-08-04 | Cyberheart, Inc. | Method for non-invasive lung treatment |
| EP1917351A4 (de) | 2005-08-01 | 2009-12-16 | Univ Technologies Int | Abgeschwächtes reovirus |
| US10668119B2 (en) | 2005-08-01 | 2020-06-02 | Virocure, Inc. | Attenuated reovirus |
| EP1984007B1 (de) | 2006-02-13 | 2015-08-19 | Oncolytics Biotech Inc. | Verwendung von niedrigdosiertem lokaler immunsuppression zur verstärkung einer onkolytischen viralen therapie |
| US10369171B2 (en) | 2007-03-13 | 2019-08-06 | Virocure, Inc. | Attenuated reoviruses for selection of cell populations |
| US9241998B2 (en) * | 2007-05-21 | 2016-01-26 | Board Of Regents, The University Of Texas System | Methods and compositions for treatment of cancer using oncolytic RSV activity |
| US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
| DE102013105144A1 (de) * | 2013-05-17 | 2014-11-20 | Arno Thaller | Pharmazeutisches Kombinationspräparat mit einem anti-idiotypischen Antikörperfragment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776743A (en) * | 1994-09-06 | 1998-07-07 | La Jolla Cancer Research Foundation | Method of sensitizing tumor cells with adenovirus E1A |
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| US6565831B1 (en) | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
| AR035227A1 (es) | 2001-02-20 | 2004-05-05 | Oncolytics Biotech Inc | Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus |
-
2003
- 2003-05-08 DK DK03724713.7T patent/DK1505993T3/da active
- 2003-05-08 WO PCT/CA2003/000695 patent/WO2003094939A1/en active Application Filing
- 2003-05-08 AU AU2003229180A patent/AU2003229180B8/en not_active Expired
- 2003-05-08 ES ES03724713T patent/ES2386779T3/es not_active Expired - Lifetime
- 2003-05-08 US US10/431,579 patent/US7198783B2/en not_active Expired - Lifetime
- 2003-05-08 BR BR0311448-1A patent/BR0311448A/pt not_active IP Right Cessation
- 2003-05-08 EP EP03724713A patent/EP1505993B1/de not_active Expired - Lifetime
- 2003-05-08 AT AT03724713T patent/ATE554781T1/de active
- 2003-05-08 JP JP2004503022A patent/JP4546823B2/ja not_active Expired - Lifetime
- 2003-05-08 CA CA2482826A patent/CA2482826C/en not_active Expired - Lifetime
- 2003-05-08 NZ NZ536062A patent/NZ536062A/en unknown
- 2003-05-08 MX MXPA04011067A patent/MXPA04011067A/es active IP Right Grant
- 2003-05-08 PT PT03724713T patent/PT1505993E/pt unknown
- 2003-05-08 SI SI200332146T patent/SI1505993T1/sl unknown
- 2003-05-08 TW TW092112546A patent/TWI300715B/zh not_active IP Right Cessation
- 2003-05-09 AR ARP030101634A patent/AR039997A1/es unknown
-
2004
- 2004-10-14 IL IL164593A patent/IL164593A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| SI1505993T1 (sl) | 2012-06-29 |
| US7198783B2 (en) | 2007-04-03 |
| NZ536062A (en) | 2008-03-28 |
| US20040091463A1 (en) | 2004-05-13 |
| ES2386779T3 (es) | 2012-08-30 |
| BR0311448A (pt) | 2005-03-15 |
| PT1505993E (pt) | 2012-05-15 |
| TW200404559A (en) | 2004-04-01 |
| TWI300715B (en) | 2008-09-11 |
| JP4546823B2 (ja) | 2010-09-22 |
| AR039997A1 (es) | 2005-03-09 |
| CA2482826A1 (en) | 2003-11-20 |
| EP1505993A1 (de) | 2005-02-16 |
| WO2003094939A1 (en) | 2003-11-20 |
| CA2482826C (en) | 2011-11-22 |
| EP1505993B1 (de) | 2012-04-25 |
| AU2003229180B8 (en) | 2009-07-02 |
| IL164593A (en) | 2015-05-31 |
| AU2003229180A1 (en) | 2003-11-11 |
| DK1505993T3 (da) | 2012-05-21 |
| MXPA04011067A (es) | 2005-02-14 |
| IL164593A0 (en) | 2005-12-18 |
| JP2005526125A (ja) | 2005-09-02 |
| AU2003229180B2 (en) | 2007-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE554781T1 (de) | Onkolytische viren zur sensibilisierung neoplastischer zellen für die strahlentherapie | |
| EP1996206A4 (de) | Sensibilisierung einer zelle gegenüber einer krebsbehandlung durch modulierung der aktivität eines nukleinsäure codierenden rps27l-proteins | |
| DE602006019236D1 (de) | Stromversorgungssystem | |
| NO20040706L (no) | Kraftgenereringssystem | |
| DK1885380T3 (da) | Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme | |
| NO20051559L (no) | System og fremgangsmate for utnyttelse av energi | |
| DE60322351D1 (de) | Reaktionszelle | |
| NO20051564L (no) | System for utnyttelse av tekniks energi | |
| MA26407A1 (fr) | Procede de preparation de combretastatines | |
| DK1553178T3 (da) | Onkolytisk virus til selektiv vækst i tumorceller | |
| DE602004005378D1 (de) | Schwimmend gelagerter Steckverbinder und dessen Herstellungsverfahren | |
| DE60220667D1 (de) | Stromquelle | |
| DE502004008433D1 (de) | Wägezelle | |
| DE50211264D1 (de) | Einrichtung zur kultivierung von zellen, insbesondere menschlicher oder tierischer zellen | |
| DE60324071D1 (de) | Katalysatorherstellungsverfahren | |
| DE10394301D2 (de) | Ultraschallreaktor | |
| ITMI20050577A1 (it) | Procedimento e impianto per la produzione di sfarinati contenenti amido scarsamente digeribile | |
| FI20041076A (fi) | Valosähkökemiallinen aurinkokenno | |
| FI20050094A0 (fi) | Teholähde | |
| FR2852022B1 (fr) | Lame de decrassage de reacteur metallurgique | |
| DE50310489D1 (de) | Brennstoffzellenanlage | |
| ITVI20030170A1 (it) | Piano di trattamento per impianto di formazione di batterie | |
| SE0302973L (sv) | Strömkälla | |
| DE602006015399D1 (de) | Vorrichtung für die Zelltherapie | |
| UA7165S (uk) | Апарат хвильової енергоінформаційної терапії |